Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-02-14 4:16 pm Sale |
2022-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
ISZO CAPITAL LP | 373,778 1.300% |
-1,551,533 (-80.59%) |
Filing History |
| 2023-02-10 2:42 pm Sale |
2023-02-14 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 1,757,544 5.900% |
-216,064 (-10.95%) |
Filing History |
| 2023-02-01 4:54 pm Sale |
2022-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
BlackRock Inc. BLK |
1,848,153 6.200% |
-98,305 (-5.05%) |
Filing History |
| 2023-01-12 5:13 pm Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
WYNNEFIELD PARTNERS SMALL CAP VALUE LP | 4,926,795 16.600% |
2,362,271 (+92.11%) |
Filing History |
| 2023-01-12 4:23 pm Purchase |
2023-01-12 | 13D | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 2,374,765 7.890% |
578,401 (+32.20%) |
Filing History |
| 2023-01-10 3:46 pm Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
22NW Fund LP | 3,096,787 9.990% |
1,341,626 (+76.44%) |
Filing History |
| 2023-01-10 09:20 am Purchase |
2023-01-09 | 13D | Lifecore Biomedical, Inc. LFCR |
Legion Partners Asset Management LLC | 2,966,540 9.990% |
38,450 (+1.31%) |
Filing History |
| 2022-12-02 4:15 pm Purchase |
2022-11-25 | 13D | Lifecore Biomedical, Inc. LFCR |
Wynnefield Partners Small Cap Value, L.P. I | 4,462,510 14.800% |
884,805 (+24.73%) |
Filing History |
| 2022-09-12 4:36 pm Purchase |
2022-08-31 | 13G | Lifecore Biomedical, Inc. LFCR |
22NW Fund LP | 1,755,161 6.000% |
1,755,161 (New Position) |
Filing History |
| 2022-02-14 1:38 pm Sale |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
Russell Investments Group Ltd. | 208,428 0.710% |
-2,383,126 (-91.96%) |
Filing History |
| 2022-02-14 12:36 pm Purchase |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
ISZO CAPITAL LP | 1,925,311 6.500% |
1,925,311 (New Position) |
Filing History |
| 2022-02-11 3:36 pm Purchase |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 1,796,364 6.090% |
187,746 (+11.67%) |
Filing History |
| 2022-02-10 08:22 am Sale |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
The Vanguard Group | 1,257,836 4.270% |
-414,005 (-24.76%) |
Filing History |
| 2022-02-08 3:52 pm Sale |
2022-02-14 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 1,973,608 6.700% |
-245,753 (-11.07%) |
Filing History |
| 2022-02-01 5:08 pm Sale |
2021-12-31 | 13G | Lifecore Biomedical, Inc. LFCR |
BlackRock Inc. BLK |
1,946,458 6.600% |
-144,572 (-6.91%) |
Filing History |
| 2022-01-20 4:16 pm Purchase |
2022-01-12 | 13D | Lifecore Biomedical, Inc. LFCR |
Wynnefield Partners Small Cap Value, L.P. I | 3,577,705 12.100% |
387,400 (+12.14%) |
Filing History |
| 2021-08-30 5:07 pm Purchase |
2021-08-26 | 13D | Lifecore Biomedical, Inc. LFCR |
Legion Partners Asset Management LLC | 2,928,090 9.940% |
23,750 (+0.82%) |
Filing History |
| 2021-04-20 4:15 pm Purchase |
2021-04-12 | 13D | Lifecore Biomedical, Inc. LFCR |
Wynnefield Partners Small Cap Value, L.P. I | 3,190,305 10.900% |
507,905 (+18.93%) |
Filing History |
| 2021-03-25 4:27 pm Purchase |
2021-03-25 | 13G | Lifecore Biomedical, Inc. LFCR |
Cove Street Capital LLC | 1,608,618 5.490% |
1,608,618 (New Position) |
Filing History |
| 2021-02-12 5:13 pm Sale |
2021-02-16 | 13G | Lifecore Biomedical, Inc. LFCR |
Dimensional Fund Advisors LP | 2,219,361 7.600% |
-212,172 (-8.73%) |
Filing History |